167 related articles for article (PubMed ID: 27788386)
1. Roles of OCT4 in tumorigenesis, cancer therapy resistance and prognosis.
Villodre ES; Kipper FC; Pereira MB; Lenz G
Cancer Treat Rev; 2016 Dec; 51():1-9. PubMed ID: 27788386
[TBL] [Abstract][Full Text] [Related]
2. Revisiting OCT4 expression in peripheral blood mononuclear cells.
Kotoula V; Papamichos SI; Lambropoulos AF
Stem Cells; 2008 Jan; 26(1):290-1. PubMed ID: 17932416
[TBL] [Abstract][Full Text] [Related]
3. Role of OCT4 in cancer stem-like cells and chemotherapy resistance.
Mohiuddin IS; Wei SJ; Kang MH
Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165432. PubMed ID: 30904611
[TBL] [Abstract][Full Text] [Related]
4. Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma.
Wang L; Guo ZY; Zhang R; Xin B; Chen R; Zhao J; Wang T; Wen WH; Jia LT; Yao LB; Yang AG
Carcinogenesis; 2013 Aug; 34(8):1773-81. PubMed ID: 23615404
[TBL] [Abstract][Full Text] [Related]
5. OCT4: dynamic DNA binding pioneers stem cell pluripotency.
Jerabek S; Merino F; Schöler HR; Cojocaru V
Biochim Biophys Acta; 2014 Mar; 1839(3):138-54. PubMed ID: 24145198
[TBL] [Abstract][Full Text] [Related]
6. Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma.
Zhao S; Yuan Q; Hao H; Guo Y; Liu S; Zhang Y; Wang J; Liu H; Wang F; Liu K; Ling EA; Hao A
J Pathol; 2011 Apr; 223(5):672-82. PubMed ID: 21341266
[TBL] [Abstract][Full Text] [Related]
7. Oct4 pseudogenes are transcribed in cancers.
Suo G; Han J; Wang X; Zhang J; Zhao Y; Zhao Y; Dai J
Biochem Biophys Res Commun; 2005 Dec; 337(4):1047-51. PubMed ID: 16229821
[TBL] [Abstract][Full Text] [Related]
8. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
[TBL] [Abstract][Full Text] [Related]
9. Implication of human OCT4 transactivation domains for self-regulatory transcription.
Lim HY; Do HJ; Lee WY; Kim DK; Seo HG; Chung HJ; Park JK; Chang WK; Kim JH; Kim JH
Biochem Biophys Res Commun; 2009 Jul; 385(2):148-53. PubMed ID: 19445899
[TBL] [Abstract][Full Text] [Related]
10. Systematic expression alteration analysis of master reprogramming factor OCT4 and its three pseudogenes in human cancer and their prognostic outcomes.
Saha SK; Jeong Y; Cho S; Cho SG
Sci Rep; 2018 Oct; 8(1):14806. PubMed ID: 30287838
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of Oct4 variants and pseudogenes in normal urothelium and urothelial cancer.
Wezel F; Pearson J; Kirkwood LA; Southgate J
Am J Pathol; 2013 Oct; 183(4):1128-1136. PubMed ID: 23933063
[TBL] [Abstract][Full Text] [Related]
12. Sox2/Oct4: A delicately balanced partnership in pluripotent stem cells and embryogenesis.
Rizzino A; Wuebben EL
Biochim Biophys Acta; 2016 Jun; 1859(6):780-91. PubMed ID: 26992828
[TBL] [Abstract][Full Text] [Related]
13. OCT4B2, a novel alternative spliced variant of OCT4, is significantly upregulated under heat-stress condition and downregulated in differentiated cells.
Poursani EM; Mehravar M; Soltani BM; Mowla SJ
Tumour Biol; 2017 Oct; 39(10):1010428317724280. PubMed ID: 29022482
[TBL] [Abstract][Full Text] [Related]
14. Distinctive expression pattern of OCT4 variants in different types of breast cancer.
Soheili S; Asadi MH; Farsinejad A
Cancer Biomark; 2017; 18(1):69-76. PubMed ID: 27814277
[TBL] [Abstract][Full Text] [Related]
15. An Overview on the Complexity of OCT4: at the Level of DNA, RNA and Protein.
Mehravar M; Ghaemimanesh F; Poursani EM
Stem Cell Rev Rep; 2021 Aug; 17(4):1121-1136. PubMed ID: 33389631
[TBL] [Abstract][Full Text] [Related]
16. Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research.
Liedtke S; Stephan M; Kögler G
Biol Chem; 2008 Jul; 389(7):845-50. PubMed ID: 18627312
[TBL] [Abstract][Full Text] [Related]
17. Impact of OCT4 and Its Related Signaling Pathways on Gastrointestinal Cancers: Focusing on Targeted Therapy.
Cheshomi H; Gholami O; Peyroshabani B; Rad A
Iran J Allergy Asthma Immunol; 2020 Jun; 19(3):229-242. PubMed ID: 32615657
[TBL] [Abstract][Full Text] [Related]
18. OCT4 expression in human uterine myometrial stem/progenitor cells.
Ono M; Kajitani T; Uchida H; Arase T; Oda H; Nishikawa-Uchida S; Masuda H; Nagashima T; Yoshimura Y; Maruyama T
Hum Reprod; 2010 Aug; 25(8):2059-67. PubMed ID: 20576635
[TBL] [Abstract][Full Text] [Related]
19. Novel Variant of OCT4, Named OCT4B5, is Highly Expressed in Human Pluripotent Cells.
Mehravar M; Poursani EM
Stem Cell Rev Rep; 2021 Jun; 17(3):1068-1073. PubMed ID: 33241484
[TBL] [Abstract][Full Text] [Related]
20. Ku80 negatively regulates the expression of OCT4 via competitive binding to SALL4 and promoting lysosomal degradation of OCT4.
Zhao B; Zheng X; Tan X; Ke K; Wang F; Wang Y; Xing X; Zhang C; Hu P; Lan S; Li Q; Huang A; Liu X
Int J Biochem Cell Biol; 2020 Jan; 118():105664. PubMed ID: 31816404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
